Monte Rosa Therapeutics Financial Overview
Monte Rosa Therapeutics's market cap is currently $1.06B. The company's EPS TTM is $-0.33; its P/E ratio is 53.41; Monte Rosa Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
